Introduction
Independent lines of research from many investigators have established`genomic instability' as one hallmark of human carcinogenesis, and such instability is considered to play a crucial role in leading to the accumulation of alterations in cellular oncogene and tumor suppressor genes necessary for malignant transformation (Loeb, 1991) . Direct measures of chromosomal numbers have shown that both gain or loss of individual chromosomes, as well as entire chromosome complements commonly accompany the malignant process (Lengauer et al., 1997b) . Equally, alterations in chromosome morphology, which are believed to proceeed via chromosomal breaks, also arise during malignant transformation and include interstitial chromosome deletions, inversions, translocations, as well as gene ampli®ctions. Mutations in the p53 tumor suppressor gene, which normally functions as the`guardian' of the genome, have been implicated as contributing to such chromosomal instability (Kao et al., 1993; Livingstone et al., 1992; Rezniko et al., 1994) . Normal wild-type p53 functions include transcriptional regulatory activity (Unger et al., 1992) and cell cycle controls at both G1 and mitotic spindle checkpoints. In contrast, p53 mutations have been associated with instability of chromosome number (Fukasawa et al., 1996; Campo et al., 1994) as well as with increased generation of chromosomal breaks as assayed either by gene ampli®cation or by generation of chromosomal translocations, inversions, or deletions.
In contrast to the large karyotypic alterations typically seen in cancer cells harboring p53 mutations, a novel form of instability of the genomic nucleotide sequence has recently been shown to arise in colorectal cancer cells in which a member of the DNA mismatch repair gene family is inactivated. In these cells elevated rates of frameshifts, transitions, and transversions Bhattacharyya et al., 1995; Kat et al., 1993) increase gene mutation rates up to 1000-fold (Eshleman et al., 1995; Bhattacharyya et al., 1994; Branch et al., 1995; Glaab and Tindall, 1997) and also destabilize repetitive DNA sequences (Umar et al., 1994) such as those found in microsatellites. Colorectal cancers demonstrating these high rates of gene mutation and demonstrating microsatellite instability, otherwise referred to as RER (for Replication ERrors) colon cancers, have conversely been noted to be more often diploid and to have lower rates of random allelic losses than do NonRER colon cancers. Also in contrast to NonRER colon cancers, RER colon cancers have been noted frequently to have wild-type p53 alleles (Ionov et al., 1993) . Thus it has been unclear whether the apparent chromosomal stability in RER colon cancers is a consequence of the presence of wild-type p53 alleles in these tumors or re¯ects other basic dierences between the carcinogenic pathways that generate RER compared with nonRER tumors.
To study dierences in the mechanisms that generate genomic instability in RER compared with NonRER colon cancers we have compared in cell lines with these phenotypes the frequencies of chromosomal gains, losses, and breaks, as well as the presence of wildtype or mutant p53 alleles. We ®nd that compared with NonRER cell lines, RER cell lines are much less likely to have acquired alterations in chromosome numbers. Additonally, RER cells are much less likely to have generated chromosome breaks. When examined for p53 mutations, such mutations were detected in all of the NonRER colon cancers. Unexpectedly, p53 gene mutations were also identi®ed in a distinct subset of four of the nine RER colon cancers. Also unexpectedly, RER colon cancers bearing mutant p53 demonstrated the same low incidence of altered chromosome number and the same low incidence of chromosome rearrangements as did RER colon cancers with wildtype p53. RER colon cancers thus maintain stability of both chromosomal number and structure, and this stability appears to be maintained by mechanisms independent of p53.
Results

RER tumor cells have stable chromosome numbers
To ®rst examine chromosomal stability in RER colon cancer cell lines we used karyotypic analysis to compare the frequency of changes in chromosomal number among a group of NonRER and RER colon cancers. From each cells line's karyotype a total aneuploid index' was calculated as the sum of all the consistent chromosomal gains or losses present in the karyotype. Thus for each monosomy or each trisomy present, a score of 1 is contributed to the aneuploid index. This index equals the sum of all the nondisjunctional events required to generate the aberrant chromosome complement in a given cancer cell line. As shown in Table 1 , the RER colon cancer cell lines with a mean aneuploid index of 3.1 demonstrated significantly fewer chromosomal gains or losses when ranked against NonRER colon cancer cell lines (P50.01) in which the mean aneuploid index was a much higher 14. Examination of the chromosome complements of the individual cell lines (Table 1) shows that the increased aneuploid index in the NonRER cell lines primarily re¯ects the propensity of many of these cell lines to have acquired hypo-triploid chromosome complements. Table 1 moreover shows that cell to cell variability of chromosome number is also more typical of NonRER colon cancers. Speci®cally, all ®ve of the NonRER lines show variation in chromosome number within the population of 10 cells examined, with Vaco576 for example ranging from 55 ± 69 chromosomes. In contrast, RER colon cancers generally show much narrower ranges of chromosome numbers; in ®ve of nine RER cell lines, no variability at all was seen in chromosome number in the 10 analysed metaphases.
RER tumor cells have stable chromosome structures
We next used karyotypic analysis to compare the frequency of aberrancy in chromosomal structure between NonRER and RER colon cancers. From each cell line's karyotype a total`break index' was calculated as the sum of all the chromosomal breaks represented by the aberrant chromosomes present in that karyotype. For example, an interstitial deletion, in which a portion in the middle of a chromosomal arm is deleted, would require breakage of the chromosome at either end of the deletion and would contribute a score of two breaks to the index. Similarly, a reciprocal translocation would also result from two scission events and would also contribute a score of two breaks to the index. As shown in Table 1 , NonRER colon cancer cell lines show an almost threefold elevated mean`break index' of 19 when compared to a The aneuploid index, break index, and chromosomal instability indices are described in results. Note that the aneuploid index does not precisely correlate with chromosome number because cell to cell variability in the presence or absence of a speci®c chromosome. b Chromosomal instability of RER and NonRER tumors are ranked in ascending order. Highlighted in bold are the four cell lines which are RER, yet harbor mutations in p53 a lower mean break index of 6.8 in the RER colon cancer cell lines. When the colon cancer cell lines were ranked according to their respective break index, the increase in chromosomal breaks in the NonRER colon cancers was statistically signi®cant at P50.05. Interestingly, some cell lines show a greater propensity toward changes in chromosome number as re¯ected by a disproportionately increased aneuploid index while others have a greater degree of chromosomal change as re¯ected by a disproportionately increased break index (e.g. compare SW837 to Vaco489).
RER colon cancers have signi®cantly greter overall chromosomal stability compared with NonRER colon cancers
As an overall measure of chromosomal instability we calculated for each colorectal cancer cell line à chromosome instability index' equal to the sum of the`aneuploid index' plus the`break index' for that tumor cell line. The decision to construct this index was made at the time of initiation of the study, and prior to actual inspection of the data. As Table 1 shows, the`chromosomal instability index' cleanly divides the NonRER colon cancer cell lines from the RER colon cancer cell lines. Whereas the NonRER colon cancer cell lines show an average chromosomal instability index of 34, with a range of from 23 ± 46, the RER colon cancer cell lines show a threefold lower mean chromosomal instability index of 9.9 with a range from 3 ± 20. Not surprisingly, when the colon cancer cell lines were ranked according to their chromosomal instability index, the increase in total chromosome changes in the NonRER colon cancers was statistically signi®cant at P=0.001. Figure 1 , which displays the frequency of alterations on each chromosomal arm in NonRER or RER colon cancers, shows that the dierence in chromosomal stability in the NonRER versus the RER colon cancers is demonstrable across the entire chromosome complement.
The increased chromosomal stability in the RER versus NonRER colon cancers can be illustrated by examining chromosome 18. Allelic loss on chromosome 18q has been demonstrated present in over 70% of colon cancers and has been taken as presumptive evidence for the presence of a colon cancer suppressor gene on 18q (Fearon et al., 1990) . Candidate suppressor genes already mapped to this region include the DCC gene, the Smad4/DPC4 gene, and the Smad2 gene (Fearon et al., 1990; Riggins et al., 1996; Eppert et al., 1996) . All ®ve of the NonRER colon cancers examined demonstrated cytogenetic loss of 18q. In three of the NonRER cell lines, this was due to complete loss of one chromosome 18 copy whereas in the other two, it was accomplished by deletion of 18q. In contrast, no monosomies of chromosome 18 and no deletions of 18q were noted in any of the RER lines, and indeed each of the RER lines contained at least two copies of cytogenetically normal chromosome 18 (P50.01, chisquare). The one 18q alteration noted in the RER group in Figure 1b re¯ects a trisomy 18 in one of the RER cell lines. Thus the increased chromosomal stability in the RER lines applies even to a chromosome that bears a candidate colon cancer suppressor gene.
Despite their general karyotypic stability, the RER cell lines do show occasional consistent cytogenetic changes. Chromosomes 7 and 8 are most commonly altered (Figure 1b) , and this alteration is generally by having three chromosomal copies. No other consistent cytogenetic changes were found among the RER cell lines, and speci®cally no changes were noted at the sites of mismatch repair gene loci that were known to be inactivated in some of these cell lines.
p53 gene mutations de®ne a distinct subset of RER colon cancers. However, RER colon cancer cell lines demonstrate chromosomal stability irrespective of whether p53 is mutant or wild-type
We initially determined the sequence of the p53 cDNA in each of the ®ve NonRER colon cancer cell lines. As expected, we found that p53 was mutant in each of these NonRER colon cancers (Table 2) . To investigate whether chromosomal stability of RER colon cancers might be due to p53 being wild-type in these cells, we determined the p53 gene sequence in these cancers also (Table 2) . Unexpectedly, we found that p53 was mutant in four of the RER colon cancers, and was wild-type in ®ve. While p53 mutations were significantly less common among RER versus NonRER colon cancers (P50.05, chi-square), our ®nding of p53 mutations in four of nine RER cases (44+17%) demonstrates a substantially higher incidence of such mutations than previous estimates (Ionov et al., 1993) . Moreover, several lines of evidence suggested that in the four RER cancers in which p53 mutations were detected, that these mutations had been biologically selected during tumorigenesis. First, among these four cell lines, the mutations in Vaco457, Vaco5 and Vaco670 have all been previously observed in other human cancers and are registered in a database of p53 mutations (Cariello et al., 1994) . Indeed, the mutation in Vaco5 is at a known CpG dinucleotide hotspot (Lehman et al., 1994) . Additionally, the heterozygous combination of a p53 Gly154?Ser mutation with a wild-type p53 allele that was noted in Vaco457 has also been previously observed in other human tumors, suggesting that this mutation may have strong dominant negative activity (Gaidano et al., 1994) . While the p53 frameshift mutation detected in Vaco703 has not been previously reported, two p53 frameshift mutations have been reported at positions 3' to the Vaco703 frameshift mutation. Finally, in each of the four RER cell lines bearing p53 mutations, it was possible to con®rm that these mutations were also present in the antecedent tumors from which the cell lines had been established.
The above ®ndings suggested that the presence of p53 mutations de®ne a genetically distinct subset of RER colon cancers. Unexpectedly, the four RER colon cancers bearing p53 mutations (Table 1, In interpreting these observations to demonstrate that RER cancers retain chromosomal stability even when p53 function has been inactivated, we presume that mutant p53 behaves in a dominant negative fashion in the two RER colon cancers which bear one mutant and one wild-type p53 allele (Vaco703 and Vaco457). However, striking stability of chromosomal number is evident even if we compare only the two RER colon cancers which demonstrate bi-allelic inactivation of p53 (Vaco5 and Vaco670) with the ®ve NonRER colon cancers which similarly demonstrte bi-allelic inactivation of p53. Speci®cally, for the two RER tumors the mean chromosomal instability index was ®ve, compared to 34 for the NonRER tumors (P50.05, t-test); the mean aneuploid index was two, compared with a value of 14 for the nonRER tumors (P50.05, t-test); and the mean break index was three, compared to 19 for the NonRER tumors (P50.05, ttest). Thus the greater chromosomal stability of the RER colon cancers represents an intrinsic feature of the RER pathway of colon carcinogenesis and is not simply due to the greater propensity of RER colon cancers to bear wild-type p53 alleles.
Discussion
We ®nd that in comparison to NonRER colon cancers, RER colon cancers show a strikingly lower incidence of chromosomal gains and losses. Furthermore, we ®nd that RER colon cancers display a markedly lower incidence of chromosomal deletions, inversions and translocations, and hence show evidence of a strikingly lower incidence of chromosome breaks. Moreover, we ®nd that the stability of both chromosomal number and structure in RER colon cancers is independent of whether p53 is mutant or wild-type in these cells. Speci®cally, like previous investigators we ®nd that p53 is mostly wild-type in RER colon cancers (Ionov et al., 1993) ; however, we also ®nd that there is a substantial subset of RER colon cancers in which p53 is mutant. Notably, these p53 mutant RER cancers display the same stability of chromosome number and structure that is typical of RER colon cancers in which p53 is wild-type. Hence, RER colon cancers that bear p53 mutations do not show the types of karyotypic alterations that are typical of p53 mutant NonRER colon cancers.
Our observation of marked chromosomal stability in RER versus NonRER colon cancers could be confounded if in our study there had been a systematic bias to examine RER colon cancers cell Mut/wt-Het Mut/wt-Het Mut-Homo Mut-Homo a Sense strand only is shown (e.g. the C→T in Vaco8 may actually be due to a G→A on the antisense strand). The mutations in SW837, Vaco5, and the G→A mutation in SW480 are known CpG dinucleotide hotspots (Lehman et al., 1994) . The mutation in SW837 and the two in SW480 reported in (Baker et al., 1990) were con®rmed. All mutations arising in RER cell lines, except Vaco703, were present in the Cariello p53 database (Cariello et al., 1994) . b p53 copy number re¯ects the number of copies determined both cytogenetically on chromosome 17 in the p53 region (17p13) and by p53 FISH. All cell lines showed identical results using both assays. c Mut=mutant, Hemi=hemizygous mutation, Homo=homozygous mutation, wt=wild type, Het=heterozygous mutation lines of younger age than the NonRER colon cancers. This is because in this study we have measured the frequency of ®nding chromosomal alterations, and such frequencies will increase with the age of a cell line. For several reasons, this eect does not account for our data. First, all of the Vaco cell lines used were established by our group, and for both RER and NonRER Vaco colon cancer cell lines karyotypes were performed on low passage cultures that had been frozen away at the time of establishing the primary cell lines. Moreover, some RER colon cancer cell lines, such as RKO, LoVO and Hct116, that were established outside our laboratory have been in culture for some years, and nonetheless still showed lower incidences of chromosomal changes than NonRER Vaco cell lines of much more recent provenance. Similarly, comparisons of the frequencies of ®nding altered chromosomes could in part be confounded if chromosome alterations more often confered a selectable advantage in NonRER compared with RER cells. However, Lengauer and colleagues have demonstrated that this is not the case with respect to chromosomal gains and losses (Lengauer et al., 1997b) . Speci®cally, these investigators have recently measured in colon cancer cell lines the rates of generating chromosomal gains or losses and have shown these rates to be markedly lower in RER versus in NonRER colon cancers (Lengauer et al., 1997b) . Our ®ndings of a low frequency of chromosomal gains and losses in RER colon cancers is thus not due to bias in selecting cell lines for comparison or to dierences in cell lines retaining chromosomal gains and losses. Similarly, our additional ®ndings of a low frequency of chromosomal breaks in RER compared to NonRER colon cancers most directly suggests that, like chromosome number, chromosomal structure is also markedly stable in RER colon cancers. Our ®ndings thus support a broader claim for the global nature of increased chromosomal stability in RER versus NonRER colon cancers.
We ®nd that in 44% of RER colon cancers p53 is mutant, and unexpectedly, that the chromosomal stability in RER colon cancers is independent of whether p53 is in these cancers mutant or wild-type. This contrasts with previous studies of other investigators that have suggested the concept that wild-type p53 is the`guardian of the genome'. This hypothesis has been supported by observations that in many tumors the acquisition of mutations in p53 correlates with the degree of cytogenetic aberrance. This is perhaps most clearly seen in the Li ± Fraumeni syndrome where tumors have acquired both a second hit in p53 and karyotypic instability (Yin et al., 1992) . Secondly, inducing functional p53 de®ciency by transfection of E6 (HPV), SV40 large T antigen, or dominant negative p53 are all associated with genomic instability. Finally, transfection of wild-type p53 appears to stabilize an otherwise progressing karyotype (Yin et al., 1992) . Such ®ndings were consistent with previous observations that suggested that RER colorectal cancers are commonly wild-type for p53 (Ionov et al., 1993) , and are often more diploid (Kouri et al., 1990; Frei, 1992; Lothe et al., 1993; Lengauer et al., 1997b) . We however have shown there is no increase in chromosomal instability in a novel group of RER cell lines that bear p53 mutations as compared with the more common RER cell lines in which p53 is wild-type. This suggests a more complicated relationship exists between p53 mutation and acquisition of chromosomal instability. In this regard we point out the recent observation by Lengauer and colleagues that RER cells robustly methylate transfected DNA sequences; whereas Non-RER cells appear to lack this likely physiologic methylation activity (Lengauer et al., 1997a) . We concur in these investigators speculation that abnormal chromosomal methylation might provide one mechanism underlying the elevated rate of chromosomal gains and losses in NonRER cancers and further suggest that abnormal methylation might also be linked to the increased number of chromosomal rearrangements present in NonRER colon cancers. In either case, our data demonstrates that p53 mutation does not invariably induce chromosomal instability. Our data further strongly support the hypothesis that the pathway of RER colon carcinogenesis is fundamentally dierent from that of NonRER colon carcinogenesis. In RER cancers a mechanism is retained that strongly acts to suppress both chromosomal gains and losses as well as chromosomal rearrangements. While the speci®c components of this mechanism or mechanisms remain to be elucidated, unexpectedly it does not appear to require the mediation of wild-type p53.
Materials and methods
Cell culture
The Vaco cell lines were generated by our group and maintained in culture as described (McBain et al., 1984) . SW837, SW480, and LoVO cell lines were obtained from the ATCC (Rockville, MD). Hct116 and RKO cell lines were a generous gift from Dr Michael Brattain, Medical College of Ohio, Toledo. The earliest available passages were used throughout. The RER assay was performed as described .
Cytogenetic analysis
Cell cultures were harvested utilizing standard techniques to yield preparations for cytogenetic analysis. Routine banded metaphases were prepared by trypsin pre-treatment followed by giemsa staining to yield GTG-bands. A minimum of 10 cells were analysed for each cell line. GTG-banded karyotypes from each cell line were constructed and analysed in detail and interpreted according to the 1995 International System for Human Cytogenetic Nomenclature Guidelines (ISCN). When an abnormality was questionable,¯uorescence in situ hybridization (FISH) with alpha-sat DNA probes and/or chromosome speci®c libraries was utilized to more precisely de®ne it. FISH was done on unstained slides, according to our previously published methods (Sullivan et al., 1996) , with minor modi®cations. After soaking in 26SSC, pH 7.0, for 1 h at 378C and rinsing in several changes of 26SSC, the slides were dehydrated in ethanol (70%, 85%, 100%) and air dried. The chromosomal DNA was denatured by immersing the slides in 70% formamide/26SSC (pH 7.0) for 2 min at 708C, and the slides were dehydrated again. Chromosome preparations were hybridized with 10 ml of the hybridization mixture (consisting of 1 mg DNA probe, 55 mg/ml sonicated herring sperm DNA, 10% dextran sulfate/26SSC, and 50% formamide at pH 7.0) and incubated overnight at 378C. After incubation, the slides were washed ®rst in 50% formamide/26SSC, then in 26SSC (®rst at 458C, then at 378C). Signal was detected using the Avadin-Fluorescein isothiocyanate ampli®cation method (Pinkel et al., 1986) . From 5 ± 10 metaphases were analysed for the presence of probe signals.
Consistent cytogenetic changes were tabulated as follows. Changes were counted as clonal if an identical chromosome abnormality was detected in at least two cells or loss of a chromosome in at least three cells. Cytogenetic alterations were independently tabulated by counting only those that were present in the majority of cells; however, since the clonal changes observed were in fact present in the overwhelming majority of cells, this alternative approach made no signi®cant dierence from those reported herein. The indexing system for tabulating cytogenetic change was decided on prior to performing the cytogenetic analysis which itself was performed in advance of the p53 analysis. All statistical comparisons of the NonRER and RER groups were performed with a two-tailed Mann-Whitney rank sum test except where indicated.
p53 sequence analysis, FISH and interpretation of p53 expression Reverse transcriptase (RT), PCR and complete cDNA sequencing for p53 were performed essentially as described (Casey et al., 1996 (Casey et al., , 1991 (Casey et al., , 1993 using an ABI377 and dye terminators. Brie¯y, total cell RNA was reverse transcribed using oligo-dT/MMLV and ampli®ed in two separate overlapping pieces of cDNA which were then sequenced with ®ve forward primers (S1, SQ1, SQ9, SQ19, SQ17). Mutations were con®rmed by sequencing the relevant area with one of four reverse primers (SQ6, SQ3, SQ8, SQ15). In two cell lines (SW837 and SW480) with previously reported mutations (Baker et al., 1990) , sequencing was limited to those regions required to con®rm the published mutations. FISH with a DNA probe which includes genomic sequences including the TP53 locus (Oncor Med, Inc.) was utilized to determine the number of p53 genes for each cell line.
The p53 status was interpreted as: wild-type if sequencing of the entire cDNA showed only wild-type sequence, heterozygous if a single mutant sequence was mixed with wild-type sequence, and homozygous or hemizygous if only a single mutant sequence was found. Cell lines bearing a single mutant p53 sequence were designated homozygous if they had two copies of chromosome 17p by karyotyping and two signals on p53 FISH, or hemizygous if they had only one 17p and one p53 FISH signal.
